Catalysts for Bio-Innova Co Ltd
3 tracked
Apr 30, 2026
phase 1 initiation
Bio-Innova Co Ltd — dapagliflozin (Phase I Trial Initiation)
DAPAGLIFLOZIN
→
Apr 28, 2026
phase 1 initiation
Bio-Innova Co Ltd — febuxostat (Phase I Trial Initiation)
febuxostat
→
Apr 28, 2026
phase 1 completion
Bio-Innova Co Ltd — clarithromycin (Phase I Trial Completion)
clarithromycin
→